Saturday, May 18, 2024

Saturday, May 18, 2024

Organization Directory

Refine Your Search Y

Type:

Filter by Org Type:

Filter By Name:


Trending

  1. 1 UROVANT SCIENCES: Announces U.S. FDA Approval of GEMTESA® (vibegron) 75 mg Tablets for the Treatment of Patients with Overactive Bladder (OAB)
FDA Health News